Concourse Financial Group Securities, Inc. Kamada LTD Call Options Transaction History
Concourse Financial Group Securities, Inc.
- $0
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding KMDA
# of Institutions
42Shares Held
4.15MCall Options Held
21KPut Options Held
0-
Jim Simons Renaissance Technologies LLC | New York, Ny832KShares$5.88 Million0.01% of portfolio
-
Wells Fargo & Company San Francisco, CA610KShares$4.32 Million0.0% of portfolio
-
Essex Investment Management CO LLC Boston, MA396KShares$2.8 Million0.48% of portfolio
-
Y.D. More Investments LTD Ramat Gan, L3270KShares$1.91 Million0.11% of portfolio
-
Acadian Asset Management LLC Boston, MA264KShares$1.86 Million0.0% of portfolio
About KAMADA LTD
- Ticker KMDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 44,800,500
- Market Cap $317M
- Description
- Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...